60651-97-0

Basic information

• Product Name: 1H-Isoindole-1-carboxylic acid, 2,3-dihydro-, Methyl ester, hydrochloride
• Synonyms: 1H-Isoindole-1-carboxylic acid, 2,3-dihydro-, Methyl ester, hydrochloride
• CAS NO: 60651-97-0
• Molecular Formula: C₁₀H₁₁NO₂*ClH
• Molecular Weight: 213.66078
• Mol File: 60651-97-0.mol
• Article Data: 2

Chemical Properties

• Melting Point: 159-161 °C(Solv: ethanol (64-17-5); ethyl ether (60-29-7))
• Appearance: /
• CAS DataBase Reference: 1H-Isoindole-1-carboxylic acid, 2,3-dihydro-, Methyl ester, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Isoindole-1-carboxylic acid, 2,3-dihydro-, Methyl ester, hydrochloride(60651-97-0)
• EPA Substance Registry System: 1H-Isoindole-1-carboxylic acid, 2,3-dihydro-, Methyl ester, hydrochloride(60651-97-0)

Safety Data

• Hazardous Substances Data: 60651-97-0(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 96016-96-5 1,3-Dihydro-2H-isoindole-1-carboxylic Acid Hydrochloride 
• 41345-72-6 3-(acetylthio)propanoyl chloride 
• 108395-22-8 octahydro-1H-isoindole-1-carboxylic acid hydrochloride 

Downstream Products

• 914298-94-5 2-(5-chloro-2,4-bis-methoxymethoxybenzoyl)-2,3-dihydro-1H-isoindole-1-carboxylic acid methyl ester 
• 444607-92-5 2-(tert-butyl) 1-methyl isoindoline-1,2-dicarboxylate 
• 96017-14-0 Dimethyl 3-Benzyl-5H-pyrrolo<2,1-a>isoindole-1,2-dicarboxylate 
• 96017-13-9 Dimethyl 3-Phenyl-5H-pyrrolo<2,1-a>isoindole-1,2-dicarboxylate 
• 96017-02-6 1,3-Dihydro-2-phenylacetyl-2H-isoindole-1-carboxylic Acid 
• 96017-01-5 2-Benzoyl-1,3-dihydro-2H-isoindole-1-carboxylic Acid 
• 96016-98-7 Methyl 1,3-Dihydro-2-phenylacetyl-2H-isoindole-1-carboxylate 
• 96016-97-6 Methyl 1,3-Dihydro-2-benzoyl-2H-isoindole-1-carboxylate 
• 96016-96-5 1,3-Dihydro-2H-isoindole-1-carboxylic Acid Hydrochloride 

Relevant articles and documents

BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS.

This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1, or a salt thereof, wherein Q, R1 , R2, R3 and R4 are as defined herein.